🔎 Trials Near Me

Home › Cancer (all types) › New York › Rochester

Cancer (all types) clinical trials in Rochester, NY

14 studies for Cancer (all types) are looking for participants at sites in and around Rochester (within about 30 miles). Open a study to see who can join and how to contact the study team.

Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →

A Study of Mocertatug Rezetecan in Combination With Anti-cancer Therapies for Advanced Solid Tumors (BEHOLD-2)

RecruitingPhase 1/2
  • GSK Investigational Site, Rochester
Ages 18 and older · All sexes · Updated Oct 2, 2026 · NCT06796907

A Study of ASP3082 in Adults With Advanced Solid Tumors

RecruitingPhase 1
  • University of Rochester Medical Center James P. Wilmot Cancer Center, Rochester
Ages 18 and older · All sexes · Updated Sep 30, 2026 · NCT05382559

A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue

RecruitingPhase 2/3
  • University of Rochester Medical Center, Rochester
Ages 18 and older · All sexes · Updated Sep 25, 2026 · NCT06989437

Exercise and Cognitive Rehab in Older Cancer Survivors

Recruiting
  • University of Rochester, Rochester
Ages 60 and older · All sexes · Updated Sep 11, 2026 · NCT05388214

A Study to Investigate Safety and Effectiveness of Tacabrutideg (BGB-16673) in Combination With Other Agents in Participants With Relapsed or Refractory B-Cell Malignancies

RecruitingPhase 1/2
  • University of Rochester, Rochester
Ages 18 and older · All sexes · Updated Sep 11, 2026 · NCT06634589

Exercise and Cognitive Rehabilitation Interventions for Older Cancer Survivors

Recruiting
  • University of Rochester, Rochester
Ages 65 and older · All sexes · Updated Sep 10, 2026 · NCT07390045

A Single Arm Pilot Trial of a Social Network Intervention

Recruiting
  • University of Rochester, Rochester
Ages 60 and older · All sexes · Updated Sep 10, 2026 · NCT05745038

Project: Every Child for Younger Patients With Cancer

RecruitingObservational study
  • University of Rochester, Rochester
Up to age 25 · All sexes · Updated Aug 25, 2026 · NCT02402244

Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer

RecruitingPhase 3
  • University of Rochester, Rochester
  • Wilmot Cancer Institute at Webster, Webster · 10 mi away
Ages 18 and older · All sexes · Updated Aug 7, 2026 · NCT06580314

A Randomized Trial of a Mobile Health Exercise Intervention for Older Adults With Myeloid Neoplasms

Recruiting
  • University of Rochester Medical Center/Wilmot Cancer Institute, Rochester
Ages 60 and older · All sexes · Updated Jul 15, 2026 · NCT04981821

A Decisional Intervention for Older Adults With Acute Myeloid Leukemia and Their Caregivers

Recruiting
  • University of Rochester Medical Center, Rochester
Ages 60 and older · All sexes · Updated Jul 6, 2026 · NCT06697600

I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer

RecruitingPhase 2
  • University of Rochester Wilmot Cancer Institute, Rochester
Ages 18 and older · All sexes · Updated May 6, 2026 · NCT01042379

Enhancing Triadic Communication About Cognition for Older Adults With Alzheimer's Disease or Related Dementias Facing a Cancer Management Decision

Recruiting
  • University of Rochester Wilmot Cancer Institute, Rochester
Ages 65 and older · All sexes · Updated Mar 24, 2026 · NCT06313853

Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma

Recruiting
  • University of Rochester, Rochester
  • Wilmont Cancer Institute at Webster, Webster · 10 mi away
Ages 18 and older · All sexes · Updated Nov 27, 2024 · NCT03860883

About Cancer (all types)

If you or someone you love has been diagnosed with cancer, learn about diagnosis, treatment, risk factors, coping and much more.

More about Cancer (all types) on MedlinePlus

Cancer (all types) trials in other cities

Other studies in Rochester

From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.